Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
LeukaemiaLymphomaOther Haematological Diseases
Interventions
OTHER

Umbilical Cord Blood Transplant

DRUG

Cyclophosphamide

RADIATION

Total body irradiation

DRUG

Busulfan

DRUG

Melphalan

DRUG

Fludarabine

Trial Locations (12)

W1T 4TJ

University College London Hospital, London

B15 2TH

University Hospital Birmingham, Birmingham

BS2 8ED

Bristol Haematology & Oncology Centre, Bristol

CB2 0QQ

Addenbrooke's Hospital, Cambridge

LS9 7TF

St James' University Hospital, Leeds

EC1A 7BE

St Bartholomew's Hospital, London

WC1N 3JH

Great Ormond Street Hospital for Children, London

M13 9WL

Manchester Royal Infirmary, Manchester

M20 4BX

Christie Hospital NHS Foundation Trust, Manchester

NG5 1PB

Nottingham City Hospital, Nottingham

S10 2JF

Royal Hallamshire Hospital, Sheffield

SM2 5PT

Royal Marsden Hospital, Sutton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER